Myeloid Biomarkers Associated with Glioblastoma Response to Anti-VEGF Therapy with Aflibercept Article

de Groot, John F, Piao, Yuji, Hai, Tran et al. (2011). Myeloid Biomarkers Associated with Glioblastoma Response to Anti-VEGF Therapy with Aflibercept . CLINICAL CANCER RESEARCH, 17(14), 4872-4881. 10.1158/1078-0432.CCR-11-0271

Open Access

cited authors

  • de Groot, John F; Piao, Yuji; Hai, Tran; Gilbert, Mark; Wu, Hua-Kang; Liu, Jun; Bekele, B Nebiyou; Cloughesy, Tim; Mehta, Minesh; Robins, H Ian; Lassman, Andrew; DeAngelis, Lisa; Camphausen, Kevin; Chen, Alice; Yung, WKA; Prados, Michael; Wen, Patrick Y; Heymach, John V

sustainable development goals

authors

publication date

  • July 15, 2011

published in

keywords

  • BEVACIZUMAB
  • CANCER-PATIENTS
  • CARBONIC-ANHYDRASE-IX
  • CELLS
  • ENDOTHELIAL GROWTH-FACTOR
  • IN-VIVO
  • Life Sciences & Biomedicine
  • MALIGNANT GLIOMA
  • Oncology
  • PHASE-II
  • RECTAL-CANCER
  • Science & Technology
  • TUMOR ANGIOGENESIS

Digital Object Identifier (DOI)

publisher

  • AMER ASSOC CANCER RESEARCH

start page

  • 4872

end page

  • 4881

volume

  • 17

issue

  • 14